aceclofenac has been researched along with Disease Models, Animal in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (11.76) | 29.6817 |
| 2010's | 13 (76.47) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Bozkurt, NM; Golgeli, A; Taskiran, M; Unal, G; Yildiz Taskiran, S | 1 |
| Katara, R; Majumdar, DK; Sachdeva, S | 2 |
| Fernández-Torres, J; López-Reyes, A; Martínez-Flores, K; Martínez-Nava, GA; Zamudio-Cuevas, Y | 1 |
| Boatto, G; Burrai, L; Chegaev, K; Cristiano, C; De Caro, C; Gazzano, E; Lazzarato, L; Magliocca, S; Marabello, D; Marini, E; Nieddu, M; Riganti, C; Rimoli, MG; Rolando, B; Russo, R; Sodano, F | 1 |
| Basu, SK; Das, A; Jana, S; Nayak, AK; Sen, KK | 1 |
| Bhandari, AB; Dhokchawle, BV | 1 |
| Boakye, CH; Godugu, C; Mendonca Faria, HA; Patel, AR; Singh, M; Somagoni, J; Zucolotto, V | 1 |
| Ganesh, M; Hemalatha, P; Jang, HT; Jeon, UJ; Peng, MM; Saravanakumar, A; Ubaidulla, U | 1 |
| Bindu, DT; Chowdary, VH; Haritha, K; Raju, YP; Satyanarayana, RP; Vandana, KR; Vinesha, V | 1 |
| Banerjee, A; Jana, S; Maiti, S; Sen, KK | 1 |
| Dua, K; Pabreja, K; Padi, SS | 1 |
| Chakraborty, S; Dinda, SC; Khanam, N; Khandai, M; Patra, ChN; Sen, KK; Sharma, A | 1 |
| Basu, SK; Jana, S; Nayak, AK; Saha, A; Sen, KK | 1 |
| Hernandez-Vaquero, D; Sandoval, MA | 1 |
| Ahuja, A; Ali, J; Aqil, M; Baboota, S; Shafiq, S; Shakeel, F | 1 |
1 review(s) available for aceclofenac and Disease Models, Animal
| Article | Year |
|---|---|
Emergent nanotherapies in microcrystal-induced arthritis.
Topics: Animals; Calcium Phosphates; Chitosan; Chondrocalcinosis; Crystal Arthropathies; Diclofenac; Disease Models, Animal; Gold; Humans; Inflammation Mediators; Nanoparticles; Peptide Hydrolases; Urate Oxidase; Uric Acid | 2018 |
16 other study(ies) available for aceclofenac and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
The long-lasting effects of aceclofenac, a COX-2 inhibitor, in a Poly I:C-Induced maternal immune activation model of schizophrenia in rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Female; Humans; Nestin; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Schizophrenia; Tumor Necrosis Factor-alpha | 2023 |
Enhancement of ocular efficacy of aceclofenac using biodegradable PLGA nanoparticles: formulation and characterization.
Topics: Administration, Ophthalmic; Animals; Arachidonic Acid; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Drug Liberation; Eye Diseases; Lactic Acid; Nanoparticles; Particle Size; Permeability; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; X-Ray Diffraction | 2017 |
Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
Topics: Acrylic Resins; Administration, Ophthalmic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cell Movement; Chemistry, Pharmaceutical; Crystallization; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Drug Liberation; Drug Stability; Eye Diseases; Inflammation; Nanoparticles; Neutrophils; Particle Size; Rabbits | 2019 |
Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations.
Topics: Acute Pain; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Caco-2 Cells; Carrageenan; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Compounding; Edema; Galactose; Gastric Mucosa; Humans; Hydrolysis; Intestinal Mucosa; Male; Mice; Permeability; Platelet Aggregation; Prodrugs; Solubility; Stomach Ulcer | 2018 |
Aceclofenac-loaded unsaturated esterified alginate/gellan gum microspheres: in vitro and in vivo assessment.
Topics: Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biocompatible Materials; Carrageenan; Delayed-Action Preparations; Diclofenac; Disease Models, Animal; Glucuronic Acid; Hexuronic Acids; Inflammation; Male; Microspheres; Polysaccharides, Bacterial; Rabbits; Rats; Rats, Sprague-Dawley | 2013 |
Synthesis, hydrolysis kinetics and pharmacological evaluation of aceclofenac prodrugs.
Topics: Acetic Acid; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Diclofenac; Disease Models, Animal; Drug Design; Drug Stability; Edema; Female; Hydrogen-Ion Concentration; Hydrolysis; Kinetics; Male; Mice; Pain; Prodrugs; Rats, Wistar; Risk Assessment; Solubility; Stomach Ulcer | 2015 |
Nanomiemgel--a novel drug delivery system for topical application--in vitro and in vivo evaluation.
Topics: Administration, Cutaneous; Aminoquinolines; Animals; Capsaicin; Cell Proliferation; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Drug Stability; Emulsions; Gels; Humans; Imiquimod; Immunohistochemistry; In Vitro Techniques; Inflammation; Keratinocytes; Micelles; Microdialysis; Microscopy, Atomic Force; Nanoparticles; Organ Size; Permeability; Psoriasis; Rats; Rheology; Skin Absorption; Spleen | 2014 |
Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac.
Topics: Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Availability; Chitosan; Crystallization; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Drug Liberation; Glucuronic Acid; Hexuronic Acids; Inflammation; Male; Particle Size; Rats; Solubility; Spectroscopy, Fourier Transform Infrared; X-Ray Diffraction | 2015 |
Formulation and Characterization of Aceclofenac -Aloe vera Transemulgel.
Topics: Aloe; Animals; Anti-Inflammatory Agents, Non-Steroidal; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Drug Stability; Edema; Gels; Hydrogen-Ion Concentration; Inflammation; Male; Rats; Rats, Wistar; Skin Absorption; Viscosity | 2015 |
Gelatin-carboxymethyl tamarind gum biocomposites: In vitro characterization & anti-inflammatory pharmacodynamics.
Topics: Animals; Anti-Inflammatory Agents; Calorimetry, Differential Scanning; Diclofenac; Disease Models, Animal; Drug Carriers; Drug Liberation; Edema; Female; Gelatin; Hydrogels; Male; Microscopy, Electron, Scanning; Polysaccharides; Rats; Spectroscopy, Fourier Transform Infrared; Tamarindus | 2016 |
Evaluation of extemporaneously manufactured topical gels containing aceclofenac on inflammation and hyperalgesia in rats.
Topics: Acrylic Resins; Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Disease Models, Animal; Edema; Female; Gels; Hyperalgesia; Inflammation; Male; Polyethylene Glycols; Rats; Rats, Wistar | 2010 |
Preparation, in vitro and in vivo evaluation of algino-pectinate bioadhesive microspheres: An investigation of the effects of polymers using multiple comparison analysis.
Topics: Adhesiveness; Administration, Oral; Alginates; Animals; Anti-Inflammatory Agents, Non-Steroidal; Delayed-Action Preparations; Diclofenac; Disease Models, Animal; Drug Carriers; Edema; Glucuronic Acid; Hexuronic Acids; Inflammation; Male; Microspheres; Pectins; Rats; Rats, Wistar; Stomach | 2010 |
Aceclofenac-loaded chitosan-tamarind seed polysaccharide interpenetrating polymeric network microparticles.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calorimetry, Differential Scanning; Carrageenan; Chitosan; Diclofenac; Disease Models, Animal; Drug Delivery Systems; Edema; Glutaral; In Vitro Techniques; Male; Microspheres; Polymers; Polysaccharides; Rats; Rats, Sprague-Dawley; Seeds; Spectroscopy, Fourier Transform Infrared; Tamarindus | 2013 |
Preventing peridural fibrosis with nonsteroidal anti-inflammatory drugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cicatrix; Connective Tissue; Diclofenac; Disease Models, Animal; Dura Mater; Epidural Space; Fibroblasts; Fibrosis; Inflammation; Laminectomy; Lumbar Vertebrae; Postoperative Complications; Rabbits; Spinal Canal; Tissue Adhesions; Treatment Outcome | 2008 |
Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
Topics: Administration, Cutaneous; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Chemistry, Pharmaceutical; Diclofenac; Diffusion Chambers, Culture; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Stability; Edema; Emulsions; Excipients; Kinetics; Male; Mice; Nanoparticles; Oils; Particle Size; Permeability; Rats; Rats, Wistar; Skin; Skin Absorption; Skin Irritancy Tests; Surface Properties; Technology, Pharmaceutical; Temperature; Viscosity; Water | 2007 |